Akkermansia muciniphila is a mucin-degrading keystone gut bacterium that supports the intestinal barrier. Its abundance falls with age, obesity and metabolic disease.
In a randomized human pilot study, pasteurized Akkermansia supplementation was safe and improved insulin sensitivity and several metabolic/inflammatory markers; in progeroid mice it modestly increased lifespan. The human evidence is early and metabolic rather than longevity-outcome data.
Peer-reviewed studies on the active compound — citations link to PubMed.
“Akkermansia muciniphila supplementation was safe and well tolerated and improved insulin sensitivity and markers of metabolic health in overweight, insulin-resistant adults.”
Research describes the active mechanism and is not a claim about this specific product.
Slightly reduces coronary mortality and events. Research relevant to this mechanism is…
Counters sarcopenia, frailty and bone loss in aging. Research relevant to this mechanism…
Counters oxidative stress accumulating with age. Research relevant to this mechanism is…
Maintains immune competence across the lifespan. Research relevant to this mechanism is…
Yes — its active compound is linked to 1 peer-reviewed study, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.